We are delighted to announce that Dan McKay has joined Panacea as our new Quality Director.
Dan has more than 15 years’ experience working in pharmacovigilance, auditing and Quality Assurance and previously worked for Panacea from 2010 to 2015. Since then he has specialised in Quality Assurance and Auditing, working as a Senior Manager and PV Auditor at AbbVie, a large multinational pharmaceutical company, and as a Senior Consultant and Head of GVP Practice at ADAMAS Consulting, a global Quality Assurance consultancy.
Dan’s appointment is a key part of Panacea’s development of its Board, ensuring that the company has the best leadership to deliver its growth plans. In his new role as Panacea’s Quality Director, Dan will lead the Quality teams which handle all matters of Quality relating to Panacea’s internal systems and processes, as well as the provision of Quality-related services to our customers. These client services include performing due diligence and vendor management, risk assessments, gap analyses, PV and Quality training, and CAPA management. In particular, Dan will be the catalyst to significantly expand Panacea’s external auditing and audit management capabilities, serving a considerable need in the industry.
Our Chairman, Stuart Colligon, commented: “I am delighted to welcome Dan back to the Panacea team. His knowledge and experience will be a huge asset to our company as we implement our growth strategy.”
Dan commented: “I am delighted to be re-joining Panacea at an exciting time in the company’s continued growth and development. Panacea’s focus on quality, efficiency and excellent customer service fits extremely well with my own. I am equally delighted to be working with an excellent team of dedicated and highly knowledgeable professionals in all areas of the business.”